anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

190,861-190,920 of 319,975

filter-aware
31
Uses bubble charts for market sizing and a donut chart for segmentation.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
32
The slide uses a waterfall-style buildup to explain the components of TSR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
33
LSD = Low Single Digits, MSD = Mid Single Digits, HSD = High Single Digits. The chart visualizes the shift from 4-6% to 6-8% CAGR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
34
Uses a before-after-bridge style visual to show margin expansion.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
35
Uses directional arrows to indicate impact on margins.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
36
The slide uses a two-column layout to distinguish between dividend policy and total shareholder return targets.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
37
Uses a numbered list to define strategic pillars.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
38
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
39
The slide uses a grid layout with three images paired with icons and descriptive text to communicate brand values.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
40
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
41
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · Solution1 hit
42
Levi Strauss | Investor Presentation Deck | 49 slidesLevi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
43
Includes footnotes explaining COVID-19 related inventory costs and acquisition-related charges.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
44
Includes footnotes (1) through (6) referenced in the table rows.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
45
The slide contains six numbered explanatory notes regarding financial adjustments.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
46
Includes two separate tables: one for Net Debt reconciliation and one for Leverage Ratio calculation.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
47
The table reconciles GAAP net income to non-GAAP adjusted net income by adding back various one-time or non-cash charges.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
48
This slide serves as a technical appendix to explain specific line items in financial reconciliation tables.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
49
Includes non-GAAP financial measure disclosure and specific footnotes regarding adjustments.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
01
Slide 1
Exhibit 99.1 indicates this is likely a regulatory or investor relations document.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
02
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
03
The slide uses a list-based summary format to establish company credibility and current operational scale.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
04
The slide uses a combination of headshots with titles and a logo grid to establish credibility.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
05
The slide features the LumiraDx device on the right and a series of test cartridge icons on the left.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
06
The slide presents a snapshot of company growth from 2019 to Q2 2022, including instrument shipments, manufacturing capacity, market reach, and revenue.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
07
The chart uses a waterfall-style visualization to show segments contributing to a total market size.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
08
Uses a process flow diagram to contrast current state (central lab) vs future state (POC).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
09
The slide uses a list of pain points on the left and illustrative examples of existing POC devices on the right.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
10
Uses a photo of a lab bench to illustrate the 'proliferation of instruments' pain point.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
11
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The slide uses a color-coded border system to distinguish between test types (Qualitative/Quantitative Immunoassay, Enzyme, Molecular).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
13
The chart uses a Gantt-style visualization to show progress across different diagnostic modalities.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
The slide showcases the physical device and a series of color-coded test cartridges for various conditions (COVID-19, HbA1c, D-Dimer, etc.).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
15
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
The visual shows four distinct test strips (INR, D-Dimer, SARS CoV-2 Ab, SARS CoV-2 Ag) to demonstrate the 'common architecture' claim.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
17
The slide uses a numbered process flow (1-8) to explain the technical mechanism of the assay.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
18
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
19
The chart uses a bar-vertical format to show relative pricing, with LumiraDx POC positioned as significantly cheaper than other POC solutions.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
20
The diagram uses concentric circles to represent layers of IP protection (Manufacturing, Assays, Microfluidic Strip, Instrument).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
21
The slide uses a horizontal arrow at the bottom to represent the strategic shift toward 'Decentralization'.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
22
The slide displays the physical device on the right and a row of 10 distinct test cartridges on the left, representing the product pipeline.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
23
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
24
The slide uses a scatter plot to demonstrate method comparison between LumiraDx and a laboratory reference (bioMérieux Vidas).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
25
The slide uses two line charts to compare positivity rates across different test methods (LumiraDx, PCR, Other POC) over time, segmented by COVID-19 variants.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
26
The slide uses a bulleted list for key value propositions and a table to demonstrate clinical sensitivity (PPA) across different Ct value thresholds.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
27
The slide uses a blue dashed box to highlight key differentiators for the company's product.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
28
The scatter plot shows a high correlation (R^2 = 0.9868) between the two testing methods.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
29
The slide uses a process diagram to explain the workflow and a combination of line charts and a comparison table to demonstrate performance feasibility.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
30
The chart shows a significant drop-off in the TB care cascade, framing the opportunity for a POC test to improve linkage to care.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
31
The slide illustrates a 3-step process: Prep Sample, Load & Run, and Report Results, with a timeline of 1 minute for prep and 2-12 minutes for results.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
32
Uses a visual 'before/after' style comparison with red X marks to indicate legacy/displaced systems.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
33
The table shows a progression from Year 1 to Year 2, and a second Year 2 column, likely representing a ramp-up or optimization scenario.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
34
The slide uses a product-centric layout to demonstrate market readiness and addressable market size for a portfolio of diagnostic tests.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
35
The slide uses a Gantt-style chart to visualize development stages (Concept to Regulatory) for multiple product lines.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
36
The slide uses a color-coded legend to distinguish between testing methodologies (Immunoassay, Molecular, Enzyme, Metabolic/Electrochemical).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
37
The slide emphasizes the breadth of the diagnostic menu available on a single hardware platform.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
38
The chart uses a waterfall-like structure to show market segments, though it is not a true waterfall as the bars do not sum to the total.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
39
The slide uses a horizontal progression to illustrate the shift from centralized lab testing to decentralized home testing.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
40
The slide uses a mix of bulleted lists and visual icons to categorize the technology's deployment across different operational models.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
41
The slide uses a process-like flow to categorize product applications.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit